Tumour subgroups | HRT use | n | HR crude | p | HR adjusted | p |
---|---|---|---|---|---|---|
beta-catenin + | No | 126 | 1.00 | 1.00 | ||
ERT | 13 | 0.93(0.52-1.64) | 0.790 | 1.04(0.58-1.84) | 0.902 | |
CHRT | 19 | 0.64(0.40-1.04) | 0.074 | 0.87(0.53-1.42) | 0.868 | |
beta-catenin − | No | 80 | 1.00 | 1.00 | ||
ERT | 7 | 0.76(0.35-1.65) | 0.490 | 0.77(0.36-1.68) | 0.516 | |
CHRT | 13 | 0.69(0.39-1.24) | 0.217 | 0.83(0.46-1.50) | 0.533 | |
cyclin D1 + | No | 173 | 1.00 | 1.00 | ||
ERT | 16 | 0.81(0.49-1.35) | 0.416 | 0.87(0.52-145) | 0.591 | |
CHRT | 29 | 0.72(0.48-1.06) | 0.096 | 0.93(0.63-1.39) | 0.734 | |
cyclin D1 − | No | 31 | 1.00 | 1.00 | ||
ERT | 4 | 1.16(0.41-3.28) | 0.782 | 1.26(0.44-3.59) | 0.661 | |
CHRT | 5 | 0.68(0.27-1.75) | 0.425 | 0.84(0.32-2.19) | 0.721 | |
p53 + | No | 99 | 1.00 | 1.00 | ||
ERT | 11 | 0.98(0.53-1.83) | 0.956 | 1.07(0.57-1.99) | 0.843 | |
CHRT | 18 | 0.78(0.47-1.29) | 0.334 | 1.00(0.59-1.65) | 0.970 | |
p53 − | No | 107 | 1.00 | 1.00 | ||
ERT | 9 | 0.74(0.37-1.45) | 0.374 | 0.79(0.40-1.55) | 0.488 | |
CHRT | 16 | 0.63(0.38-1.07) | 0.089 | 0.84(0.49-1.42) | 0.508 | |
MSI | No | 38 | 1.00 | 1.00 | ||
ERT | 1 | 0.23(0.03-1.63) | 0.140 | 0.24(0.03-1.72) | 0.154 | |
CHRT | 5 | 0.56(0.22-1.43) | 0.225 | 0.80(0.31-2.06) | 0.649 | |
MSS | No | 164 | 1.00 | 1.00 | ||
ERT | 18 | 0.97(0.60-1.58) | 0.903 | 1.06(0.65-1.72) | 0.829 | |
CHRT | 28 | 0.73(0.49-1.09) | 0.120 | 0.92(0.61-1.39) | 0.700 |